CIK 0001844417 · <br>Emerging growth company
Estrella Immunopharma, Inc.
Sign in to watch- Ticker
- ESLA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 861314502
- Phone
- (510) 318-9098
- Business address
- 5858 HORTON STREET, SUITE 370, EMERYVILLE, CA, 94608
- Former names
- TradeUP Acquisition Corp.
Securities
- ESLA Common Stock Nasdaq
- ESLAW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-02 | Pussinen Cynthia Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +1,000,000 | 1,000,000 | ||
| 2026-08-25 | Liu Cheng CEO | Option exercise | +100,000 | $0.82 | $82K | 397,437 |
| 2026-08-25 | Liu Cheng CEO | Option exercise · Incentive Stock Option | +100,000 | 900,000 | ||
| 2026-08-18 | Xu Jiandong Chief Financial Officer | Option exercise | +100,000 | $0.82 | $82K | 365,488 |
| 2026-08-18 | Xu Jiandong Chief Financial Officer | Option exercise · Incentive Share Option | −100,000 | 390,796 | ||
| 2025-10-07 | Xu Jiandong Chief Financial Officer | Purchase | +1,000 | $1.33 | $1K | 265,488 |
| 2025-09-22 | Xu Jiandong Chief Financial Officer | Purchase | +1,000 | $1.16 | $1K | 16,700 |
| 2025-09-11 | Xu Jiandong Chief Financial Officer | Purchase | +100 | $1.04 | $104 | 264,588 |
| 2024-10-30 | Liu Cheng Chief Executive Officer | Grant or award · Incentive Share Option | +490,796 | 490,796 | ||
| 2024-10-30 | Liu Cheng Chief Executive Officer | Grant or award · Nonstatutory Share Option | +509,204 | 509,203 | ||
| 2024-10-30 | Xu Jiandong Chief Financial Officer | Grant or award · Incentive Share Option | +490,796 | 490,796 | ||
| 2024-10-30 | Xu Jiandong Chief Financial Officer | Grant or award · Nonstatutory Share Option | +509,204 | 509,203 | ||
| 2023-09-29 | Owl Creek Asset Management, L.P. 10% owner | Other disposition | −255,000 | $10.86 | $2.8M | 0 |
| 2022-03-04 | Li Jianwei Co-Chief Executive Officer | Purchase | +141,970 | $314,700.00 | $44.7B | 1,253,730 |
Page 1 of 1 · 14 trades